Skip to content
10-Q

Quarterly Report

NxStage Medical, Inc.

0001333170-18-000013

← back to feed
Filed
Nov 7, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Nov 1, 2018 66.68M sh
Shares Diluted Q3 2018 · Sep 30, 2018 68.01M sh
Shares Diluted Q3 2018 · Sep 30, 2018 66.52M sh
Shares Diluted Q3 2018 · Sep 30, 2017 66.08M sh
Shares Diluted Q3 2018 · Sep 30, 2017 65.72M sh
Capex Q3 2018 · Sep 30, 2018 $4.36M
Capex Q3 2018 · Sep 30, 2017 $7.55M
Long Term Debt Q3 2018 · Sep 30, 2018 $444K
Long Term Debt Q3 2018 · Dec 31, 2017 $520K
Short Term Debt Q3 2018 · Sep 30, 2018 $101K
Short Term Debt Q3 2018 · Dec 31, 2017 $101K
Cash And Equivalents Q3 2018 · Sep 30, 2018 $81.94M
Cash And Equivalents Q3 2018 · Dec 31, 2017 $64.93M
Cash And Equivalents Q3 2018 · Sep 30, 2017 $62.98M
Cash And Equivalents Q3 2018 · Dec 31, 2016 $59.63M
Stockholders Equity Q3 2018 · Sep 30, 2018 $225.19M
Stockholders Equity Q3 2018 · Dec 31, 2017 $213.16M
Current Liabilities Q3 2018 · Sep 30, 2018 $58.76M
Current Liabilities Q3 2018 · Dec 31, 2017 $47.43M
Total Liabilities Q3 2018 · Sep 30, 2018 $151.84M
Total Liabilities Q3 2018 · Dec 31, 2017 $112.65M
Current Assets Q3 2018 · Sep 30, 2018 $211.24M
Current Assets Q3 2018 · Dec 31, 2017 $153.37M
Total Assets Q3 2018 · Sep 30, 2018 $377.45M
Total Assets Q3 2018 · Dec 31, 2017 $325.63M
Eps Diluted Q3 2018 · Sep 30, 2018 $0.00
Eps Diluted Q3 2018 · Sep 30, 2018 $0.00
Eps Diluted Q3 2018 · Sep 30, 2017 $0.00
Eps Diluted Q3 2018 · Sep 30, 2017 $0.00
Eps Basic Q3 2018 · Sep 30, 2018 $0.01
Eps Basic Q3 2018 · Sep 30, 2018 −$0.05
Eps Basic Q3 2018 · Sep 30, 2017 −$0.14
Eps Basic Q3 2018 · Sep 30, 2017 −$0.19
Sga Expense Q3 2018 · Sep 30, 2018 $9.39M
Sga Expense Q3 2018 · Sep 30, 2018 $29.6M
Sga Expense Q3 2018 · Sep 30, 2017 $12.62M
Sga Expense Q3 2018 · Sep 30, 2017 $31.24M
Rd Expense Q3 2018 · Sep 30, 2018 $9.7M
Rd Expense Q3 2018 · Sep 30, 2018 $29.73M
Rd Expense Q3 2018 · Sep 30, 2017 $11.22M
Rd Expense Q3 2018 · Sep 30, 2017 $29.76M
Net Income Q3 2018 · Sep 30, 2018 $881K
Net Income Q3 2018 · Sep 30, 2018 −$3.17M
Net Income Q3 2018 · Sep 30, 2017 −$8.45M
Net Income Q3 2018 · Sep 30, 2017 −$11.72M
Operating Income Q3 2018 · Sep 30, 2018 $1.26M
Operating Income Q3 2018 · Sep 30, 2018 −$957K
Operating Income Q3 2018 · Sep 30, 2017 −$8.28M
Operating Income Q3 2018 · Sep 30, 2017 −$12.02M
Gross Profit Q3 2018 · Sep 30, 2018 $46.53M
Gross Profit Q3 2018 · Sep 30, 2018 $138.65M
Gross Profit Q3 2018 · Sep 30, 2017 $40.61M
Gross Profit Q3 2018 · Sep 30, 2017 $122.96M
Cost Of Revenue Q3 2018 · Sep 30, 2018 $61.59M
Cost Of Revenue Q3 2018 · Sep 30, 2018 $183.75M
Cost Of Revenue Q3 2018 · Sep 30, 2017 $56.69M
Cost Of Revenue Q3 2018 · Sep 30, 2017 $167.38M
Revenue Q3 2018 · Sep 30, 2018 $108.12M
Revenue Q3 2018 · Sep 30, 2018 $322.39M